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Background/aim: The aim was to investigate the protective and therapeutic effects of ghrelin, which has antioxidant and antiinflammatory
activity, on preventing kidney damage that occurs by induced partial ureteral obstruction in rats.
Materials and methods: Twenty-eight adult male rats were included in the study, and the rats were divided into 4 groups. After the
laparotomy operation on the sham group, the ureter was identified in the retroperitoneal area and was duly sutured (n = 7). Ghrelin
was administered for seven days intraperitoneally, and after the nephrectomy performed on the 15th day, the rats were sacrificed (n =
7). A partial ureteral obstruction was performed after the laparotomy on the PUO group. The rats were sacrificed after the nephrectomy
operation performed on the 15th day (n = 7). A partial ureteral obstruction was formed after the laparotomy followed by seven days of
waiting in the PUO + ghrelin group. Ghrelin was given in the dose of 10 ng/kg per day intraperitoneally for the next 7 days, and the rats
were sacrificed after the nephrectomy operation performed on the 15th day (n = 7). All groups were evaluated for histological damage
and catalase, superoxide dismutase, total glutathione, malondialdehyde, and myeloperoxidase levels were measured in the same tissues.
Results: When the 2nd group and the sham group were compared histologically, it was observed that the damage had increased by a
statistically significant level in the partial ureteral obstruction group (P = 0.001). When the group which was ghrelin-treated after the
partial ureteral obstruction was compared to the group with just partial ureteral obstruction, the histopathological changes were found
to decrease significantly in that group (P = 0.001). While the statistical significance of the levels of CAT, GSH, and MPO enzymes was
detected among biochemical changes in the 2nd group when compared to the sham group (P < 0.01), the 3rd group showed a statistically
significant difference in the levels of SOD and GSH enzymes compared to the 4th group (P < 0.05).
Conclusion: Ghrelin administration to rats after the formation of an experimental partial unilateral ureteral obstruction reduces tissue
damage due to ghrelin’s antiinflammatory and antioxidant effects. Ghrelin administration may prevent tissue damage biochemically and
histopathologically in obstructive uropathy cases.
Key words: Partial ureteral obstruction, ghrelin, protective effect, kidney

1. Introduction
Urinary tract obstruction is a pathological condition that
can occur with the agenesis of the urinary system, the
increase in intraluminal pressure, urinary stones, and
infection. This can occur in an obstructed ureter, as well as
in both ureters, and this may lead to damage to one kidney
or both.
The most common cause of unilateral ureteral
obstruction in adults is kidney and/or ureteral calculi
(1). Upper urinary tract obstructions and treatment
spectrum are quite wide pathologies. The level and

degree of obstruction and whether it is acute or chronic
play an important role in determining the treatment
to be planned. Due to the fact that the upper urinary
tract obstructions may result in organ loss, they have an
important role in urology practice. This obstruction leads
to renal parenchymal damage if not eliminated (2). The
main purpose of treatment is to maintain the functional
reserve of the kidney and/or to provide some recovery by
eliminating the obstruction.
Experimental studies aimed at preventive treatments
for renal parenchymal damage that may occur following
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an obstructive uropathy and nephropathy are thought to
be more important in the future. Experimental studies
created with well-designed partial ureteral obstruction
models in rats can show the obstructive uropathy formed
also in humans, at a good level (3,4).
Ghrelin was first identified in the stomach of rats by
Japanese scientists Kojima et al. in 1999 (5). The ghrelin
cells with endocrine functions present in the oxyntic
mucosa of the stomach are produced by (X/A) (6,7). This
hormone is synthesized, other than the stomach, in the
hypothalamus, pituitary, salivary glands, thyroid gland,
small intestine, kidneys, heart, central nervous system,
lungs, placenta, gonads, immune system, breasts, teeth,
and alpha, beta, and epsilon cells of the pancreas (8–12).
Ghrelin can be used as a treatment in many diseases such
as growth retardation, heart failure, osteoporosis, and
immune system suppression (13). Today, ghrelin has been
shown to have antiinflammatory and antioxidant effects in
light of successful clinical studies (14).
In those studies, it has been shown that, besides these
effects, ghrelin has an antioxidant effect, and thus inhibits
oxidative stress and apoptosis that can occur in tissues
(15,16). Ghrelin has numerous biological effects such as
modulating cell proliferation and survival, inhibition
of inflammation, regulation of immune functions, and
regulation of cardiovascular actions (17–23).
However, in the literature, there is no study investigating
the possible protective effects of ghrelin administration in
the presence of obstruction for renal damage.
In our study, we aimed to investigate the protective
effects of ghrelin in the treatment and/or prevention of
the renal damage induced by partial ureteral obstruction
(PUO) experimentally formed in rats.
2. Materials and methods
Our study was conducted with the approval of the İnönü
Experimental and Clinical Research Ethics Committee
(Project No: 2007/17). The study was performed in the
İnönü University Experimental Animal Research and
Application Center, with the contributions of the İnönü
University Faculty of Medicine’s Department of Histology
and the İnönü University Science Faculty’s Department of
Biochemistry. In the study, 28 adult male Wistar albino rats
were used, which were approximately 4 months old, fed
with standard feed and fountain water, kept in the same
room for 12 h in a nighttime environment and for 12 h in
a daytime environment, weighing in the range of 250–300
g, and raised in the experimental animal research center.
All rats were given 100 mg/kg cefazolin sodium
intraperitoneally for preoperative surgical prophylaxis.
Rats were not fed for 12 h before surgery, but water
intake was not limited. In order to create anesthesia, the
combination of 40 mg/kg ketamine hydrochloride (Ketalar,

Eczacıbaşı, İstanbul) and 8 mg/kg xylazine (Rompun,
Bayer AG, Leverkusen, Germany) was administered by
intraperitoneal injection before the surgical procedure.
PUO was formed according to the technique of Ulm and
Miller (24). The abdominal skin of the rats was shaved, and
laparotomy was performed with a midline incision under
sterile conditions. The intestines were taken medially, and
the left kidney and the left ureter were found (Figure 1).
After the insertion of the left ureter into the fissure created
in the psoas, both sides of the psoas were approached with
a 6/0 polypropylene (Prolene, Ethicon) suture (Figure 2).
The front wall of the abdomen was closed one by one, with
4/0 silk sutures.
2.1. Experimental groups
Each experimental group included 7 rats.
Sham group: The rats in this group underwent
laparotomy, and the ureters were identified in the
retroperitoneal area. They were freed and closed again
without any ureter obstruction formation. After the
nephrectomy performed on the 15th day, rats were
sacrificed (n = 7).
Ghrelin group: Partial ureteral obstruction was not
formed, but intraperitoneal ghrelin was administered for
seven days, and after the nephrectomy was performed on
the 15th day, the rats were sacrificed (n = 7).
PUO group: The rats in this group underwent
laparotomy, and the ureters were found in the retroperitoneal
area with partial ureteral obstruction formation. Following
this procedure, 7 days were allowed, and 0.5 mL of saline
per day was administered intraperitoneally for the next 7

Figure 1. The midline incision in the rats, and the deviation of
the intestines in the midline and the presence of the left kidney
and ureter.
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direction variance analysis was used (one-way ANOVA
test), and for multiple comparisons between groups,
Tamhane’s and independent t-tests were used. All results
were reported as arithmetic mean ± standard error (X ±
SE), and P < 0.05 was considered as statistically significant.

Figure 2. The insertion of the left ureter into the fissure in the
psoas muscle and closing of the psoas muscle with the Prolene
suture.

days. After the nephrectomy performed on the 15th day,
the rats were sacrificed (n = 7).
PUO + ghrelin group: The partial ureteral obstruction
was formed, and 7 days were allowed. For the next 7 days,
a ghrelin dose of 10 ng/kg per day was administered
intraperitoneally, and the rats were sacrificed after
nephrectomy performed on the 15th day (n = 7).
At the end of the study, all rats were sacrificed under
general anesthesia with high-dose ketamine chloride.
2.2. Histological analysis
For histopathological evaluation, the kidney tissues
of rats were divided into small sections of 3–4 mm.
Hematoxylin and eosin (H&E) stainings were performed
in sections to observe the general histological structure.
The intertubular hemorrhage, peritubular infiltration,
glomerular congestion, and glomerular capillary collapse
parameters were evaluated to determine the renal damage.
At 20× magnification, 10 sites from each section were
examined, and histopathological scoring was determined
by the level and the prevalence of renal damage. According
to the severity of damage, 0 was evaluated as no change, 1
as mild, 2 as moderate, and 3 as severe.
2.3. Biochemical analysis
Catalase (CAT), superoxide dismutase (SOD),
myeloperoxidase (MPO), lipid peroxidation (MDA), and
total glutathione (tGSH) analyses were performed to
determine the enzyme activity in tissues.
2.4. Statistical analysis
Statistical analysis was performed with SPSS 17 for
Windows. The results were evaluated using one-way
ANOVA, Tamhane’s T2, and independent t-tests. Single
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3. Results
3.1. Histopathological findings
In the kidney sections of the rats in the sham group,
the glomerulus and tubule structures in the cortex were
observed to have normal histological structure (Figure
3). In the kidney sections of the rats in the ghrelin group,
the histological appearance of the glomeruli and tubules
present in the renal cortex was similar to that of the
control group (Figure 4). In the kidney tissue samples of
the rats in the PUO group, significant hemorrhage and
infiltration areas were seen in the intertubular area in the
cortex (Figure 5). Changes such as glomerular congestion
and collapse were observed in some glomeruli (Figure
6). In this group, the histopathological damage score was
calculated as 5.71 ± 0.18. When compared to the control
group, it was seen that the damage in this group increased
by a statistically significant level (P = 0.001) (Table 1).
Although the renal tissue was histologically normal
in the renal pathological sections of the rats in the
PUO + ghrelin group, local inflammation areas were

Figure 3. The glomerulus (star) and tubular structures (arrows)
in the renal tissue of the control group are observed as normal,
H&E, 20×.
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Figure 4. The glomerulus (star) and tubular structures (arrows)
in the renal tissue of the ghrelin group are observed as normal,
H&E, 20×.

observed (Figure 7). Compared to the PUO group, the
histopathological changes also decreased by a statistically
significant level in this group (1.42 ± 0.52) (P = 0.001).
3.2. Biochemical findings
When the sham and PUO groups were compared in terms
of biochemical findings, a statistically significant change
in CAT, GSH, and MPO levels were observed (P < 0.05).
However, SOD and MDA levels remained the same. When
the PUO and PUO + ghrelin groups were compared,
the SOD and GSH levels were found to be statistically
significant (P < 0.05). There was no change in CAT, MDA,
and MPO levels (Table 2).
4. Discussion
Partial ureteral obstruction is an occlusion that can occur
anywhere in the ureter; so, it is a pathology that results
in the obstruction of urinary flow (1). If the obstruction
is not eliminated, it may progress to kidney loss. Many
etiological causes lead to this situation (25). There is an
increase in pressure after postrenal obstruction. This
increase leads to dilatation in the collecting duct system,
increased fibroblast activity in the interstitial area, increase
in the mononuclear cells, an increase in the number of
macrophages, and an inflammatory process starting in
the cells. The formation of free oxygen radicals leads to
nephron loss through apoptosis and interstitial fibrosis

Figure 5. The intertubular hemorrhage (arrows) and infiltration
areas (stars) are observed in the renal tissue of the PUO group,
H&E, 20×.

in the cells, following a chain of events beginning after
the release of the cytokines that are not fully elucidated
today. These nephrons do not augment because of the
lack of mitotic activity after nephron damage occurs
in the kidney (26). In the event of being delayed in the
obstruction case, permanent damage to the kidney may
occur even if the obstruction is eliminated. If not treated,
it can cause morbidity and mortality (25). An intervention
to any of these stages or any substances going to be given
may prevent the progression of nephron damage. If the
mechanisms of deterioration in renal function following
the elimination of the obstruction can be revealed, the
damage in the kidney can be reduced by pharmacological
agents to be used for this condition.
There are many studies in the literature performed
using antiinflammatory, antioxidant, and antiapoptotic
agents to reduce and/or eliminate kidney damage that
occurs as a result of PUO.
In a study conducted by Miyajima et al., the effects
on renal tubular damage and interstitial fibrosis were
examined in rats in which unilateral ureteral obstruction
(UUO) was formed by giving etodolac, which is a COX2 inhibitor, in a dose of 10 mg/kg for 2 weeks. In the
obstructed kidney, the tissue prostaglandin E2 (PGE2)
production, transforming growth factor beta (TGF-β)
level, tubular apoptosis, and interstitial fibrosis were
determined to increase. The tissue PGE2 production,
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Table 1. Histological damage scoring of all groups.

a
b

Groups

Histological damage

Sham

0.42 ± 0.20

Ghrelin

0.57 ± 0.20

PUO

5.71 ± 0.18a

PUO + ghrelin

1.42 ± 0.52b

Statistically significant difference with sham group (P = 0.001).
A statistically significant difference with PUO group (P = 0.001).

Figure 6. The glomerular congestion (arrows) and collapse (star)
are observed in some glomeruli in the PUO group, H&E, 20×.

TGF-β concentration, tubular apoptosis, and interstitial
fibrosis in the group treated with etodolac were observed
to decrease significantly. Etodolac has been stated to be
a promising agent in preventing UUO-induced renal
damage (27).
In another study by Miyajima et al., N-anthranilic acid
(tranilast), an antiallergic agent, was initiated on the day
before the operation in rats, in which UUO was formed. In
the postoperative period, 150 mg/kg was given for 14 days,
and tranilast was shown to decrease the tubular apoptosis
and increase the tubular proliferation in the tissue,
according to the control group. These findings suggest that
tranilast is an important agent in terms of preventing the
renal tubular damage in UUO (28).
In a study by He et al., UUO was formed in rats, and
the effect of losartan on the renal tubular cell apoptosis
and renal cell fibrosis was evaluated. As a result, losartan
was shown to decrease the renal fibrosis and tubule cell
apoptosis in UUO (29). In the study performed by Topçu
et al., it was found that verapamil reduced the renal tubular
apoptosis in rats in which a partial UUO was formed (30).
In the literature, there are many studies investigating
the effects of ghrelin in different experimental models.
In a study performed by Güven et al., ghrelin
was given to some rats, which were traumatized and
developed acute lung injury. This damage was found to
significantly heal. It was concluded that this occurred
through the antiinflammatory activity of ghrelin (31).
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Figure 7. In the PUO + ghrelin group, although renal tissue
appears histologically normal, inflammatory inflammation is still
observed in some areas (arrows), H&E, 20×.

In the neurological injury models created as a result
of traumatic brain damage, a significant decrease in
apoptosis was observed in ghrelin-treated rats compared
to the other groups, and this was thought to be due to the
antiinflammatory, antioxidant, and neuroprotective effects
of ghrelin (32).
In a study conducted by Golestan et al. for evaluation
of the protective role of ghrelin on liver toxicity due to
overdose intake of acetaminophen, it was found that
ghrelin reduced liver damage by means of the antioxidant
and antiinflammatory effects in the given group when
compared to other groups (33).
In a study of the protective effects of ghrelin in rats
in which paracetamol-induced acute hepatotoxicity was
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Table 2. Biochemical analysis results of all groups.

a
b

CAT
(U/mg protein)

SOD
(U/mg protein)

GSH
(nmol/mg protein)

MDA
(nmol/g wet tissue)

MPO
(U/g wet tissue)

Sham

590.77 ± 56.22

3.82 ± 0.14

3.02 ± 0.28

69.39 ± 19.36

8.65 ± 2.73

Ghrelin

681.77 ± 126.55

4.65 ± 0.37

2.67 ± 0.23

48.53 ± 20.09

8.85 ± 2.41

PUO

484.81 ± 73.32a

3.52 ± 0.39

1.59 ± 0.41a

100.47 ± 22.36

18.54 ± 3.25a

PUO + ghrelin

571.19 ± 126.25

4.16 ± 0.28

2.77 ± 0.19

51.90 ± 7.54

10.42 ± 1.62

b

b

Statistically significant difference with sham group (P < 0.05).
A statistically significant difference with PUO group (P < 0.05).

formed, it was observed that in the ghrelin group, the
CAT, SOD, and GSH levels increased while the MPO and
MDA levels decreased significantly, and histopathological
changes showed improvement compared to the control
group. It is concluded that these effects were derived from
the antioxidant and antiinflammatory effects of ghrelin
(34).
In a study conducted by Pamukçu et al., the
antiinflammatory activity of ghrelin was analyzed in a
rat colitis model formed with dextran sulfate sodium.
The MDA level, which is the major indicator of oxidative
damage in tissues, and the MPO level, which is the
indicator of inflammation, were found to be significantly
decreased in the ghrelin group compared to the other
groups. In addition, in the ghrelin-treated group, it was
determined that the inflammatory cytokines decreased and
antiinflammatory cytokines increased in response (35).
In a study conducted by Khowailed et al. about the
effects of ghrelin on acute kidney damage caused by
sepsis, in the ghrelin group, a decrease in the MPO levels
was determined compared to the control group and other
groups. Ghrelin was found to treat this damage through its
antiinflammatory and antioxidant effects (36).
In another study on the role of ghrelin in rats with
acute hepatic toxicity formed with carbon tetrachloride,
a significant decrease in tissue MDA and MPO levels was
found in the ghrelin group compared to the other groups.
On the other hand, it was found to significantly reduce the
acute congestion and inflammation in histopathological
evaluation (37).

Also, in our study, it was seen that in the rats in
which PUO was formed, ghrelin was observed to cause
a decrease in kidney glomerular structure congestion,
interstitial inflammation, and glomerular hemorrhagic
areas histologically compared to the other groups. In
the same tissues, there was a decrease in the MPO level,
which was involved in the inflammatory process and
was released from leukocytes. Moreover, it was observed
that the ghrelin treatment decreased the MDA level,
which had increased due to the oxidative damage, and
increased antioxidant levels such as CAT, SOD, and
GSH. It was concluded that ghrelin inhibited these effects
through antiinflammatory, antiapoptotic, and antioxidant
mechanisms.
In conclusion, despite the use of various agents in
the prevention of renal damage after PUO in studies, no
standard was established for treatment. This may result
from the fact that the cause of kidney damage is not
fully established, and studies are still in the experimental
stage. In cases where urinary obstruction is encountered
clinically, we suggest that ghrelin treatment be used until
the obstruction is eliminated so that the obstruction does
not cause further loss of function. In order for ghrelin to
be used clinically, larger series and multicenter studies are
needed.
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